Comparison of application of different methods to estimate lifetime cardiovascular risk

被引:6
作者
Brotons, Carlos [1 ,2 ]
Calvo-Bonacho, Eva [3 ]
Moral, Irene [1 ,2 ]
Puig, Mireia [1 ,2 ]
Garcia-Margallo, Maria T. [4 ]
Cortes-Arcas, Maria V. [4 ]
Catalina-Romero, Carlos [3 ]
Quevedo-Aguado, Luis [3 ]
Ruilope, Luis M. [5 ]
机构
[1] Biomed Res Inst Sant Pau IIB Sant Pau, Sardenya Primary Hlth Care Ctr, Res Unit, C Sardenya 466, Barcelona 08025, Spain
[2] Teaching Unit Family Med ACEBA, Barcelona, Spain
[3] Ibermutuamur, Madrid, Spain
[4] Sociedad Prevenc Ibermutuamur, Madrid, Spain
[5] Hosp Univ Doce Octubre, Inst Invest, Madrid, Spain
关键词
Risk assessment; cardiovascular disease; risk factors; ACC/AHA GUIDELINES; DISEASE; PREVENTION; VALIDATION; DERIVATION; IMPACT;
D O I
10.1177/2047487315579616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Recent guidelines recommend assessment of lifetime cardiovascular risk on the basis of traditional risk factors in adults who are not at high short-term risk. The aim of this study is to determine the implications of estimating the lifetime cardiovascular risk in individuals in a large occupational cohort in Spain. Design National cross-sectional study in an occupational cohort with an in-person interview including laboratory tests. Methods Volunteer workers who were examined between January 2011 and December 2011 were included. A total of 580,236 workers were eligible during this year and 259,834 were examined (participation rate of 44.7%). Short-term (10-year) and lifetime cardiovascular risk were estimated using the American College of Cardiology (ACC) and the American Heart Association (AHA) tool and the QRISK2 and QRISK. Results Sixty-eight per cent were male, mean age was 39 years, with an age range of 16 to 75 years. Total number of individuals included in this study was 258,676. The percentage of patients at high short-term risk was 6.85% (95% confidence interval (CI) 6.75%-6.95% and 20.83% (95% CI 20.60%-21.07%) with the QRISK2, and the ACC/AHA risk equations, respectively. Of the percentage of patients classified as not at high risk with the different tools 1.61% (95% CI 1.55%-1.66%) were high lifetime risk on QRISK, and 27.41% (95% CI 27.11%-27.70%) on ACC/AHA risk. Conclusions Application of lifetime cardiovascular risk engages greater numbers of individuals at high risk with substantial differences between the different methods available. These differences can have important clinical implications specifically in the percentage of candidates for lifestyle changes and eventually lipid lowering drugs.
引用
收藏
页码:564 / 571
页数:8
相关论文
共 20 条
  • [1] [Anonymous], 2011, NCD MORT MORB
  • [2] Lifetime Risks of Cardiovascular Disease
    Berry, Jarett D.
    Dyer, Alan
    Cai, Xuan
    Garside, Daniel B.
    Ning, Hongyan
    Thomas, Avis
    Greenland, Philip
    Van Horn, Linda
    Tracy, Russell P.
    Lloyd-Jones, Donald M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) : 321 - 329
  • [3] Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review
    Brindle, P.
    Beswick, A.
    Fahey, T.
    Ebrahim, S.
    [J]. HEART, 2006, 92 (12) : 1752 - 1759
  • [4] Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: results of the ICARIA study
    Calvo-Bonacho, Eva
    Miguel Ruilope, Luis
    Angel Sanchez-Chaparro, Miguel
    Cerezo, Cesar
    Catalina-Romero, Carlos
    Martinez-Munoz, Paloma
    Banegas, Jose R.
    Waeber, Bernard
    Gonzalez-Quintela, Arturo
    Zanchetti, Alberto
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (05) : 299 - 306
  • [5] Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
    Conroy, RM
    Pyörälä, K
    Fitzgerald, AP
    Sans, S
    Menotti, A
    De Backer, G
    De Bacquer, D
    Ducimetière, P
    Jousilahti, P
    Keil, U
    Njolstad, I
    Oganov, RG
    Thomsen, T
    Tunstall-Pedoe, H
    Tverdal, A
    Wedel, H
    Whincup, P
    Wilhelmsen, L
    Graham, IM
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (11) : 987 - 1003
  • [6] General cardiovascular risk profile for use in primary care - The Framingham Heart Study
    D'Agostino, Ralph B.
    Vasan, Ramachandran S.
    Pencina, Michael J.
    Wolf, Philip A.
    Cobain, Mark
    Massaro, Joseph M.
    Kannel, William B.
    [J]. CIRCULATION, 2008, 117 (06) : 743 - 753
  • [7] Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)
    Deanfield, John
    Simpson, Iain
    Bradbury, Kirsten
    Fox, Keith
    Boon, Nick
    Winocour, Peter
    Feher, Michael
    Doherty, Patrick
    Buckley, John
    Jennings, Catriona
    Keenan, Jan
    Weissberg, Peter
    Knapton, Mike
    Williams, Bryan
    Poulter, Neil
    Stevens, Paul
    Taal, Maarten
    Grant, Peter
    Home, Philip
    Sattar, Naveed
    Rees, Alan
    Neely, Dermot
    Wheeler, David
    Goldsmith, David
    Potter, John
    Jackson, Stephen
    [J]. HEART, 2014, 100 : 1 - 67
  • [8] Distribution of short and lifetime risks for cardiovascular disease in Italians
    Di Castelnuovo, Augusto
    Costanzo, Simona
    Persichillo, Mariarosaria
    Olivieri, Marco
    de Curtis, Amalia
    Zito, Francesco
    Donati, Maria Benedetta
    de Gaetano, Giovanni
    Iacoviello, Licia
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (04) : 723 - 730
  • [9] Goff DC, 2014, CIRCULATION, V129, pS49, DOI [10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005]
  • [10] An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia - Full report
    Grundy, Scott M.
    Arai, Hidenori
    Barter, Philip
    Bersot, Thomas P.
    Betteridge, D. John
    Carmena, Rafael
    Cuevas, Ada
    Davidson, Michael H.
    Genest, Jacques
    Kesaniemi, Y. Antero
    Sadikot, Shaukat
    Santos, Raul D.
    Susekov, Andrey V.
    Sy, Rody G.
    LaleTokgozoglu, S.
    Watts, Gerald F.
    Zhao, Dong
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (01) : 29 - 60